Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: A multicenter prospective trial

Journal of Clinical Oncology

Volumn 20, Issue 21, 2002, Pages 4331-4337

  Trümper, Lorenz ^a   Menges, Markus ^a   Daus, Heiner ^a   Köhler, Daniel ^a   Reinhard, Jan Olaf ^a   Sackmann, Michael ^a   Moser, Cornelius ^a   Sek, Alexandra ^a   Jacobs, Georg ^a   Zeitz, Martin ^a   Pfreundschuh, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL TRIAL; CODON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ONCOGENE RAS; PANCREAS CANCER; PANCREAS JUICE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS;

EID: 0036842198     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.06.068     Document Type: Article

References (52)

1. Warshaw AL, Fernandez-del-Castillo C: Pancreatic carcinoma. N Engl J Med 326:455-465, 1992
2. Bramhall SR, Allum WH, Jones AG, et al: Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study. Br J Surg 82:111-115, 1995
3. Almoguera C, Shibata D, Forrester K, et al: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549-554, 1988
4. Grunewald K, Lyons J, Frohlich A, et al: High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinoms. Int J Cancer 15:1037-1041, 1989
5. Shibata D, Almoguera C, Forrester K, et al: Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Cancer Res 50:1279-1283, 1990
6. Stork P, Loda M, Bosari S, et al: Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Oncogene 6:857-862, 1991
7. Motojima K, Tsunoda T, Kanematsu T, et al: Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann Surg 214:657-662, 1991
8. Motojima K, Urano T, Nagata Y, et al: Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. Am J Gastroenterol 86:1784-1788, 1991
9. Berthelemy P, Bouisson M, Escourrou J, et al: Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 123:188-191, 1995
10. Kondo H, Sugano K, Fukayama N, et al: Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 73:1589-1594, 1994
11. Daus H, Trumper L, Burger B, et al: Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas. Dtsch Med Wochenschr 120:821-825, 1995
12. Iguchi H, Sugano K, Fukayama N, et al: Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology 110:221-226, 1996
13. Binder HJ: ERCP meets C-K-ras: Towards an improved diagnosis of pancreatic cancer. Gastroenterology 110:311-317, 1996
14. Capella G, Cronauer-Mitra S, Pienado MA, et al: Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect 93:125-131, 1991
15. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 39:525-532, 1988
16. Trumper L, Burger B, von-Bonin F, et al: Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions. Br J Cancer 70:278-284, 1994
17. Jacobs G, Tscholl E, Sek A, et al: Enrichment polymerase chain reaction for the detection of Ki-ras mutations: Relevance of Taq polymerase error rate, initial DNA copy number, and reaction conditions on the emergence of false-positive mutant bands. J Cancer Res Clin Oncol 125: 395-401, 1999
18. Roesch T, Lorenz R, Braig C, et al: Endosonographic diagnosis of pancreatic tumors [in German]. Dtsch Med Wochenschr 115:1339-1347, 1990
19. Kahn SM, Jiang W, Culbertson TA, et al: Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification. Oncogene 6:1079-1083, 1991
20. Axon AT: Endoscopic retrograde cholangiopancreatography in chronic pancreatitis: Cambridge classification. Radiol Clin Am 27:39-50, 1989
21. Steinberg W: The clinical utility of the CA-19-9 tumor associated antigen. Am J Gastroenterol 85:350-355, 1990
22. Bottger TC, Boddin J, Duber C, et al: Diagnosing and staging of pancreatic carcinoma: What is necessary? Oncology 55:122-129, 1998
23. Gilinsky NH, Bornman PC, Girgwood AH, et al: Diagnostic yield of endoscopic retrograde cholangiopancreatography in carcinoma of the pancreas. Br J Surg 73:539-543, 1986
24. Pasanen P, Partanen K, Pikkarainen P, et al: Diagnostic accuracy of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the detection of pancreatic cancer in patients with jaundice or cholestasis. In Vivo 6:297-301, 1992
25. Menges M, Lerch MM, Zeitz M: The double duct sign in patients with malignant and benign pancreatic lesions. Gastrointest Endosc 52:74-77, 2000
26. Foutch PG, Kerr DM, Harlan JR, et al: Endoscopic retrograde wire-guided brush cytology for diagnosis of patients with malignant obstruction of the bile duct. Am J Gastroenterol 85:791-795, 1990
27. Kubota Y, Takaoka M, Tani K, et al: Endoscopic transpapillary biopsy for diagnosis of patients with pancreaticobiliary ductal strictures. Am J Gastroenterol 88:1700-1704, 1993
28. Sugiyama M, Atomi Y, Wada N, et al: Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: A prospective comparative study with bile and brush cytology. Am J Gastroenterol 91:465-467, 1996
29. Van Laethem JL, Bourgeois V, Parma J, et al: Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases. Gastrointest Endosc 47:479-485, 1998
30. Sturm PD, Rauws EA, Hruban RH, et al: Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis. Clin Cancer Res 5:629-635, 1999
31. Niederau C, Grendell JH: Diagnosis of pancreatic carcinoma. Pancreas 7:66-71, 1992
32. Lerma E, Musulen E, Cuatrecasas M, et al: Fine needle aspiration cytology in pancreatic pathology. Acta Cytol 40:683-686, 1996
33. Enayati PG, Traverso LW, Galagan K, et al: The meaning of equivocal pancreatic cytology in patients thought to have pancreatic cancer. Am J Surg 171:525-528, 1996
34. Nakamura R, Machado R, Amikura K, et al: Role of fine needle aspiration cytology and endoscopic biopsy in the preoperative assessment of pancreatic and peripancreatic malignancies. Int J Pancreatol 16:17-21, 1994
35. Grimm H, Maydeo A, Soehendra N: Endoluminal ultrasound for the diagnosis and staging of pancreatic cancer. Baillieres Clin Gastroenterol 4:869-888, 1990
36. Yasuda K, Mukai H, Fujimoto S, et al: The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest Endosc 34:1-8, 1988
37. Roesch T, Lorenz R, Braig C, et al: Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 37:347-352, 1991
38. Suits J, Frazee R, Erickson RA: Endoscopic ultrasound and fine needle aspiration for the evaluation of pancreatic masses. Arch Surg 134:639-642, 1999
39. Fritscher-Ravens A, Izbicki JR, Sriram PV, et al: Endosonography-guided, fine-needle aspiration cytology extending the indication for organ-preserving pancreatic surgery. Am J Gastroenterol 95:2255-2260, 2001
40. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer: Adopted on May 17, 1996, by the American Society of Clinical Oncology. J Clin Oncol 14:2843-2877, 1996
41. Huber KR, Bittner J, Bauer K, et al: Restriction digest PCR (RD-PCR) for the analysis of gene mutations: Application to Ki-ras. Clin Chem Lab Med 36:593-598, 1998
42. Furuya N, Kawa S, Akamatsu T, et al: Long-term follow-up of patients with chronic pancreatitis and k-ras gene mutation detected in pancreatic juice. Gastroenterology 113:593-598, 1997
43. Tada M, Ohashi M, Shiratori Y, et al: Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 110:227-231, 1996
44. Lin S, Chen P, Wang C, et al: Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method. Am J Clin Pathol 100:686-689, 1993
45. Watanabe M, Asaka M, Tanaka J, et al: Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 107:1147-1153, 1994
46. Wenger F, Zieren J, Peter F, et al: K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis. Langenbecks Arch Surg 384:181-186, 1999
47. Hanada K, Tsuchida A, Iwao T, et al: Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol 94:1638-1642, 1999
48. Panzer-Grumayer ER, Schneider M, Panzer S, et al: Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia. Blood 95:790-794, 2000
49. Brennan JA, Mao L, Hruban RH, et al: Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332:429-435, 1995
50. Brentnall TA, Chen R, Lee JG, et al: Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55:4264-4267, 1995
51. Hahn SA, Bartsch D, Schroers A, et al: Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res 58:1124-1126, 1998
52. Kita K, Saito S, Morioka CY, et al: Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes. Int J Cancer 80:553-558, 1999